TipRanks
Rasna Therapeutics Inc (RASP)
OTHER OTC:RASP
US Market
RASP
Rasna Therapeutics
RESEARCH TOOLSreports

Rasna Therapeutics (RASP) Income Statement

3 Followers

Rasna Therapeutics Income Statement

Last quarter (Q2 2024), Rasna Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Rasna Therapeutics's net income was $-95.52K. See Rasna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -314.00$ -1.64K-
Operating Expenses
$ 4.24M$ 383.91K$ 247.81K$ 556.50K$ 915.17K
Depreciation and Amortization
$ 184.21K$ 314.00$ 314.00$ 1.64K$ 3.47K
EBITDA
$ -4.05M$ 254.72K$ -247.69K$ -555.00K$ -912.93K
Operating Income
$ -4.24M$ 141.09K$ -248.00K$ -5.43M$ -915.17K
Other Income/Expenses
$ -204.00K$ -828.00K$ -628.00K$ 79.15K$ -28.79K
Pretax Income
$ -4.44M$ -687.00K$ -876.00K$ -5.35M$ -943.96K
Net Income
$ -4.44M$ -687.00K$ -876.00K$ -5.35M$ -936.38K
Per Share Metrics
Basic EPS
$ >-0.01$ -0.01$ -0.01$ -0.08$ -0.01
Diluted EPS
$ >-0.01$ >-0.01$ -0.01$ -0.08$ -0.01
Weighted Average Shares Outstanding
 578.02M 68.66M 68.91M 68.91M 68.91M
Weighted Average Shares Outstanding (Diluted)
 578.02M 111.43M 68.91M 68.91M 68.91M
Currency in USD

Rasna Therapeutics Earnings and Revenue History